- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Synthesis of JAK2 Inhibitor BMS-911543 ; volume:11 ; number:09 ; year:2015 ; pages:0899-0899
Synfacts ; 11, Heft 09 (2015), 0899-0899
- DOI
-
10.1055/s-0034-1378765
- URN
-
urn:nbn:de:101:1-2019011106172511513952
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Other Objects (12)
Synthesis of BMS-741672
Synthesis of BMS-663068
Synthesis of BMS-932481
Synthesis of BMS-644950
Synthesis of BMS-741672
Synthesis of BMS-986158
Commercial Synthesis of BMS-663068
Synthesis of the Tricyclic Core of BMS-986251
Der JAK2-Inhibitor Fedratinib : Myelofibrose Therapie neu denken
Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2 V617F-induced myeloproliferative neoplasms
Bms
BMS
Synthesis of BMS-741672
Synthesis of BMS-663068
Synthesis of BMS-932481
Synthesis of BMS-644950
Synthesis of BMS-741672
Synthesis of BMS-986158
Commercial Synthesis of BMS-663068
Synthesis of the Tricyclic Core of BMS-986251
Der JAK2-Inhibitor Fedratinib : Myelofibrose Therapie neu denken
Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2 V617F-induced myeloproliferative neoplasms
Bms
BMS
Synthesis of BMS-741672
Synthesis of BMS-663068
Synthesis of BMS-932481
Synthesis of BMS-644950
Synthesis of BMS-741672
Synthesis of BMS-986158
Commercial Synthesis of BMS-663068
Synthesis of the Tricyclic Core of BMS-986251
Der JAK2-Inhibitor Fedratinib : Myelofibrose Therapie neu denken
Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2 V617F-induced myeloproliferative neoplasms
Bms